{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:19:38Z","timestamp":1794565178429,"version":"4.9.1"},"reference-count":35,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Krabbe disease is a rare neurodegenerative disorder caused by a deficiency in galactocerebrosidase. The only effective treatment is hematopoietic stem cell transplantation (HSCT). Approximately 85% of Krabbe disease cases are the infantile subtypes, among which \u223c20% are late infantile. Prior studies have demonstrated that HSCT is effective for early-infantile patients (0-6 months of age) who undergo transplantation while asymptomatic, compared with those receiving transplants while symptomatic. However, no studies evaluated the efficacy of HSCT for late-infantile patients (6-36 months). In this prospective, longitudinal study, patients were evaluated at a single site according to a standardized protocol. Survival analysis was performed using the Kaplan-Meier method. Differences between groups were estimated using mixed regression models to account for within-person repeated measures. Nineteen late-infantile patients underwent HSCT (March 1997 to January 2020). Compared with untreated patients, transplant recipients had a longer survival probability and improved cognitive and language function. Gross and fine motor development were most affected, with variable results. Asymptomatic patients benefitted the most from transplantation, with normal to near-normal development in all domains and some gross motor delays. Among symptomatic patients, those with disease onset at &amp;gt;12 months of age had better cognitive outcomes than untreated patients. Those with disease onset at \u226412 months were comparable to untreated patients. We found that HSCT prolonged the lifespan and improved the functional abilities of late-infantile patients with Krabbe disease, particularly those who underwent transplantation before onset of symptoms. In addition, our findings support prior literature that reclassifies late-infantile Krabbe disease to be symptom onset at 12 to 36 months of age.<\/jats:p>","DOI":"10.1182\/blood.2020005477","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T21:58:02Z","timestamp":1604527082000},"page":"1719-1730","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":52,"title":["Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease"],"prefix":"10.1182","volume":"137","author":[{"given":"Isabel C.","family":"Yoon","sequence":"first","affiliation":[{"name":"Program for the Study of Neurodevelopment in Rare Disorders, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Bascou","sequence":"additional","affiliation":[{"name":"Program for the Study of Neurodevelopment in Rare Disorders, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele D.","family":"Poe","sequence":"additional","affiliation":[{"name":"Program for the Study of Neurodevelopment in Rare Disorders, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-4076","authenticated-orcid":false,"given":"Paul","family":"Szabolcs","sequence":"additional","affiliation":[{"name":"Program for the Study of Neurodevelopment in Rare Disorders, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Escolar","sequence":"additional","affiliation":[{"name":"Program for the Study of Neurodevelopment in Rare Disorders, Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"1","key":"2021040115260973900_B1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13023-018-0872-9","article-title":"A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life","volume":"13","author":"Bascou","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2021040115260973900_B2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","article-title":"Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications","volume":"10","author":"Wenger","year":"1997","journal-title":"Hum Mutat"},{"key":"2021040115260973900_B3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cca.2013.01.017","article-title":"Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease","volume":"419","author":"Chuang","year":"2013","journal-title":"Clin Chim Acta"},{"key":"2021040115260973900_B4","article-title":"Krabbe Disease.","author":"Orsini","year":"2018"},{"issue":"3","key":"2021040115260973900_B5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pediatrneurol.2011.05.007","article-title":"Early infantile Krabbe disease: results of the World-Wide Krabbe Registry","volume":"45","author":"Duffner","year":"2011","journal-title":"Pediatr Neurol"},{"key":"2021040115260973900_B6","volume-title":"et al. Scriver\u2019s The Online Metabolic and Molecular Bases of Inherited Disease","author":"Krabbe disease","year":"2019"},{"issue":"5","key":"2021040115260973900_B7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pediatrneurol.2012.02.023","article-title":"Later onset phenotypes of Krabbe disease: results of the world-wide registry","volume":"46","author":"Duffner","year":"2012","journal-title":"Pediatr Neurol"},{"issue":"20","key":"2021040115260973900_B8","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","article-title":"Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease","volume":"352","author":"Escolar","year":"2005","journal-title":"N Engl J Med"},{"issue":"13","key":"2021040115260973900_B9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","article-title":"Developmental outcomes of cord blood transplantation for Krabbe disease: A 15-year study","volume":"89","author":"Wright","year":"2017","journal-title":"Neurology"},{"issue":"16","key":"2021040115260973900_B10","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM199804163381605","article-title":"Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy","volume":"338","author":"Krivit","year":"1998","journal-title":"N Engl J Med"},{"issue":"11","key":"2021040115260973900_B11","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.bbmt.2018.06.020","article-title":"Long-Term Functional Outcomes after Hematopoietic Stem Cell Transplant for Early Infantile Krabbe Disease","volume":"24","author":"Allewelt","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2021040115260973900_B12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jon.12502","article-title":"Hematopoietic Stem Cell Transplantation in Late-Onset Krabbe Disease: No Evidence of Worsening Demyelination and Axonal Loss 4 Years Post-allograft","volume":"28","author":"Laule","year":"2018","journal-title":"J Neuroimaging"},{"issue":"2","key":"2021040115260973900_B13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1212\/01.wnl.0000230156.01228.33","article-title":"Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation","volume":"67","author":"Siddiqi","year":"2006","journal-title":"Neurology"},{"issue":"457","key":"2021040115260973900_B14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1651-2227.2008.00651.x","article-title":"Methods for assessing neurodevelopment in lysosomal storage diseases and related disorders: a multidisciplinary perspective","volume":"97","author":"Martin","year":"2008","journal-title":"Acta Paediatr"},{"issue":"13","key":"2021040115260973900_B15","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/bloodadvances.2020001940","article-title":"Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders","volume":"4","author":"Vander Lugt","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2021040115260973900_B16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","article-title":"Psychosine, a marker of Krabbe phenotype and treatment effect","volume":"121","author":"Escolar","year":"2017","journal-title":"Mol Genet Metab"},{"key":"2021040115260973900_B17","article-title":"Mullen scales of early learning AGS edition","author":"Mullen","year":"1995"},{"key":"2021040115260973900_B18","article-title":"Differential ability scales","author":"Elliott","year":"1990"},{"key":"2021040115260973900_B19","article-title":"Differential ability scales","author":"Elliott","year":"2007","edition":"2nd ed"},{"issue":"1","key":"2021040115260973900_B20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0022-3476(05)81587-2","article-title":"Clinical Adaptive Test\/Clinical Linguistic Auditory Milestone Scale in early cognitive assessment","volume":"123","author":"Hoon","year":"1993","journal-title":"J Pediatr"},{"key":"2021040115260973900_B21","article-title":"Peabody developmental motor scales","author":"Folio","year":"2000","edition":"2nd ed"},{"key":"2021040115260973900_B22","article-title":"Bruininks-Oseretsky Test of Motor Proficiency","author":"Bruininks","year":"1978"},{"key":"2021040115260973900_B23","article-title":"Bruininks-Oseretsky test of motor proficiency","author":"Bruininks","year":"2005","edition":"2nd ed"},{"key":"2021040115260973900_B24","article-title":"Scales of Independent Behavior-Revised. SIB-R","author":"Bruininks","year":"1996"},{"key":"2021040115260973900_B25","first-page":"1","article-title":"Vineland adaptive behavior scales. Encyclopedia of clinical neuropsychology","author":"Burger-Caplan","year":"2018"},{"issue":"246","key":"2021040115260973900_B26","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","volume":"11","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"key":"2021040115260973900_B27","first-page":"243","article-title":"Describing sequence variants using HGVS nomenclature. Genotyping","author":"den Dunnen","year":"2017"},{"issue":"12","key":"2021040115260973900_B28","doi-asserted-by":"crossref","first-page":"E1894","DOI":"10.1002\/humu.21367","article-title":"Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease","volume":"31","author":"Tappino","year":"2010","journal-title":"Hum Mutat"},{"key":"2021040115260973900_B29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/JCM.S40470","article-title":"Predominant Corticospinal Tract Involvement in a Late Infant with Krabbe Disease","volume":"7","author":"Yoshimura","year":"2016","journal-title":"Jpn Clin Med"},{"issue":"2","key":"2021040115260973900_B30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuroimage.2005.08.017","article-title":"Pediatric diffusion tensor imaging: normal database and observation of the white matter maturation in early childhood","volume":"29","author":"Hermoye","year":"2006","journal-title":"Neuroimage"},{"issue":"5","key":"2021040115260973900_B31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3174\/ajnr.A1476","article-title":"Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease","volume":"30","author":"Escolar","year":"2009","journal-title":"AJNR Am J Neuroradiol"},{"issue":"3","key":"2021040115260973900_B32","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbmt.2013.11.021","article-title":"A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases","volume":"20","author":"Parikh","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2021040115260973900_B33","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"issue":"11","key":"2021040115260973900_B34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/jnr.23891","article-title":"Clinical management of Krabbe disease","volume":"94","author":"Escolar","year":"2016","journal-title":"J Neurosci Res"},{"issue":"1","key":"2021040115260973900_B35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13023-019-1018-4","article-title":"Early progression of Krabbe disease in patients with symptom onset between 0 and 5\u2009months","volume":"14","author":"Beltran-Quintero","year":"2019","journal-title":"Orphanet J Rare Dis"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/13\/1719\/1804229\/bloodbld2020005477.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/137\/13\/1719\/1804229\/bloodbld2020005477.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:36:51Z","timestamp":1617277011000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/137\/13\/1719\/474073\/Long-term-neurodevelopmental-outcomes-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":35,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020005477","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}